A
Alistair Lumb
Researcher at University of Oxford
Publications - 17
Citations - 372
Alistair Lumb is an academic researcher from University of Oxford. The author has contributed to research in topics: Diabetes mellitus & Health care. The author has an hindex of 8, co-authored 17 publications receiving 145 citations. Previous affiliations of Alistair Lumb include Churchill Hospital & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Hybrid closed-loop therapy: Where are we in 2021?
Lalantha Leelarathna,Pratik Choudhary,Emma G. Wilmot,Emma G. Wilmot,Alistair Lumb,Tim Street,Partha Kar,Sze May Ng +7 more
TL;DR: Comparing the currently available commercial hybrid closed‐loop systems in the UK provides consensus recommendations to develop pragmatic pathways to guide patients, clinicians and commissioners in making informed decisions on the appropriate use of the diabetes technology.
Journal ArticleDOI
Predicting the Risk of Inpatient Hypoglycemia With Machine Learning Using Electronic Health Records
Yue Ruan,Yue Ruan,Alexis Bellot,Alexis Bellot,Zuzana Moysova,G. D. Tan,G. D. Tan,Alistair Lumb,Alistair Lumb,Jim Davies,Mihaela van der Schaar,Mihaela van der Schaar,Rustam Rea,Rustam Rea +13 more
TL;DR: Advanced machine learning models are superior to logistic regression models in predicting the risk of hypoglycemia in inpatients with diabetes and trials of such models should be conducted in real time to evaluate their utility to reduce inpatient hypoglyCEmia.
Peer ReviewDOI
Author response for "Hybrid Closed‐loop therapy: Where are we in 2021?"
Lalantha Leelarathna,Pratik Choudhary,Emma G. Wilmot,Alistair Lumb,Tim Street,Partha Kar,Sze May Ng +6 more
Journal ArticleDOI
Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID-19 pandemic.
Gerry Rayman,Alistair Lumb,Brian Kennon,C. Cottrell,Dinesh Nagi,E. Page,D. Voigt,H. Courtney,H. Atkins,J. Platts,K. Higgins,Ketan Dhatariya,Mayank Patel,Parth Narendran,Partha Kar,P. Newland-Jones,Rose Stewart,O. Burr,Stephen Thomas +18 more
TL;DR: During the early stages of the CO VID‐19 pandemic, hospitals in London, the UK epicentre, reported an unusually high number of people presenting with COVID‐19 disease developing diabetic ketoacidosis, hyperosmolar hyperglycaemic state, or a combination of both.
Journal ArticleDOI
Guidelines for the management of diabetes services and patients during the COVID-19 pandemic.
Gerry Rayman,Alistair Lumb,Brian Kennon,C. Cottrell,Dinesh Nagi,E. Page,D. Voigt,H. Courtney,H. Atkins,J. Platts,Kath Higgins,Ketan Dhatariya,Mayank Patel,Parth Narendran,Partha Kar,Philip Newland-Jones,Rose Stewart,O. Burr,Stephen Thomas +18 more
TL;DR: The UK National Diabetes Inpatient COVID Response Group was formed at the end of March 2020 to support the provision of diabetes inpatient care during the COVID pandemic and has produced two sets of guidelines which will be continually revised as new evidence emerges.